Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(3.92)
# 605
Out of 5,246 analysts
336
Total ratings
41.75%
Success rate
13.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $50.36 | +58.86% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $68.32 | +9.78% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $75.56 | -13.98% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $22.02 | -36.42% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $11.61 | +761.33% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $60.61 | -25.75% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $29.37 | +155.36% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $32.47 | -7.61% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $16.62 | +164.74% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $16.80 | -40.48% | 16 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $17.45 | -42.68% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $12.60 | +138.10% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $8.18 | +1,428.12% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $16.35 | -8.26% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.44 | +247.22% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $8.67 | -42.33% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.76 | +32.98% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $5.11 | +193.54% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $27.71 | +62.40% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.76 | +8.70% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.76 | +491.72% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.88 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.35 | +418.52% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $4.36 | -31.19% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $2.26 | -11.50% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.07 | +741.12% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.44 | +175.74% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $976,320,000 → $372,222,000 | $0.5149 | +72,290,153,327.85% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.38 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $50.36
Upside: +58.86%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $68.32
Upside: +9.78%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $75.56
Upside: -13.98%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $22.02
Upside: -36.42%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $11.61
Upside: +761.33%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $60.61
Upside: -25.75%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $29.37
Upside: +155.36%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $32.47
Upside: -7.61%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $16.62
Upside: +164.74%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $16.80
Upside: -40.48%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $17.45
Upside: -42.68%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $12.60
Upside: +138.10%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $8.18
Upside: +1,428.12%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $16.35
Upside: -8.26%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.44
Upside: +247.22%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $8.67
Upside: -42.33%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $3.76
Upside: +32.98%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $5.11
Upside: +193.54%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $27.71
Upside: +62.40%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.76
Upside: +8.70%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $6.76
Upside: +491.72%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $15.88
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.35
Upside: +418.52%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $4.36
Upside: -31.19%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $2.26
Upside: -11.50%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.07
Upside: +741.12%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.44
Upside: +175.74%
Sep 6, 2023
Maintains: Buy
Price Target: $976,320,000 → $372,222,000
Current: $0.5149
Upside: +72,290,153,327.85%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $2.38
Upside: -